GlassScriptPhysician profile
Michael A Mcguire
NPI 1043356066
$6,252.59
in general payments reported to CMS, 2019-2025
53 companies · $1,147 in 2025
The $1,147 reported for 2025 was more than what 88% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,061 · 2020: $701 · 2021: $910 · 2022: $696 · 2023: $916 · 2024: $822 · 2025: $1,147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,885.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,884.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,109.44 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $746.74 | 2020-2025 | |
| Astrazeneca Pharmaceuticals LP | $640.13 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Pfizer INC. | $514.28 | 2019-2025 | |
| Glaxosmithkline, LLC. | $381.01 | 2019-2025 | Trelegy Ellipta, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $342.85 | 2019-2024 | Jardiance, Synjardy, Tradjenta |
| Amarin Pharma, INC. | $220.30 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $195.29 | 2022-2025 | Xifaxan |
| Amgen INC. | $144.29 | 2019-2023 | Repatha, Otezla |
| Otsuka America Pharmaceutical, INC. | $132.66 | 2020-2025 | Rexulti |
| Novartis Pharmaceuticals Corporation | $131.75 | 2019-2024 | |
| Allergan, INC. | $125.98 | 2019-2020 | |
| Lilly USA, LLC | $124.80 | 2019-2025 | Kisunla |
| Merck Sharp & Dohme LLC | $108.78 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $103.24 | 2021-2024 |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $93.18 | 2024-2025 | Cologuard Collection Kit |
| Sanofi Pasteur INC. | $92.58 | 2019-2023 | |
| Abbott Laboratories | $76.02 | 2022-2025 | Freestyle Libre 2, Freestyle Libre 3 |
| Astellas Pharma US INC | $71.99 | 2019-2025 | Veozah |
| Vertos Medical, INC. | $66.47 | 2024 | Mild Device Kit |
| Biohaven Pharmaceuticals, INC. | $54.89 | 2021 | |
| Sanofi-Aventis U.S. LLC | $54.46 | 2023-2024 | |
| Teva Pharmaceuticals USA, INC. | $45.87 | 2021-2024 | Austedo Xr |
| Kowa Pharmaceuticals America, INC. | $43.08 | 2019-2022 | |
| Phathom Pharmaceuticals, INC. | $40.00 | 2024 | Voquezna |
| Genentech USA, INC. | $39.86 | 2019 | |
| Eisai INC. | $39.75 | 2020-2021 | |
| E.R. Squibb & Sons, L.L.C. | $35.64 | 2019-2025 | Eliquis |
| Almatica Pharma LLC | $33.00 | 2021-2025 | Loreev Xr |
| Intra-Sana Laboratories | $32.54 | 2025 | Reltone 200 Mg, Glycate, Reltone 400 Mg |
| Axsome Therapeutics, INC. | $31.35 | 2025 | Symbravo |
| Gilead Sciences, INC. | $26.18 | 2019 | |
| Hologic Sales and Service, LLC | $25.42 | 2025 | Thinprep 2000 Processor, Aptima |
| Xeris Pharmaceuticals, INC. | $21.31 | 2023 | Gvoke Hypopen |
| Amneal Pharmaceuticals LLC | $20.99 | 2025 | Unithroid |
| Radius Health, INC. | $19.58 | 2024 | Tymlos |
| Seqirus USA INC | $18.77 | 2023 | Fluad Quadrivalent, Flucelvax Quadrivalent |
| Inspire Medical Systems, INC. | $18.68 | 2024 | Inspire |
| Biohaven Pharmaceutical Holding Company LTD. | $18.36 | 2022 | |
| Dermira, INC. | $18.09 | 2020 | |
| Linus Health, INC. | $18.00 | 2023 | |
| Vbi Vaccine (Delaware) INC. | $16.27 | 2022 | |
| Aytu Biopharma, INC. | $16.17 | 2020 | |
| Appliedvr INC | $15.79 | 2025 | Relievrx |
| Phadia US INC. | $15.70 | 2023 | Immunocap |
| Janssen Pharmaceuticals, INC | $15.20 | 2019 | |
| Irhythm Technologies, INC. | $14.78 | 2024 | Zio Monitor, Zio Xt Patch |
| Si-Bone, INC. | $14.12 | 2023 | |
| Idorsia Pharmaceuticals US INC | $13.92 | 2024 | Quviviq |
| Shire North American Group INC | $13.67 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $13.27 | 2022 | |
| Currax Pharmaceuticals LLC | $13.10 | 2023 | Contrave |
| Jazz Pharmaceuticals INC. | $13.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Mcguire listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.